Clinical Trial Update: Fludarabine Phosphate and Total-Body Irradiation Before Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating fludarabine phosphate with total-body irradiation as conditioning before donor peripheral blood stem cell transplantation in patients w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Prolymphocytic Leukemia
• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma
• T-cell Prolymphocytic Leukemia

Drugs mentioned

• Fludarabine phosphate (Fludarabine phosphate)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: B-Cell Prolymphocytic Leukemia, Chronic Lymphocytic Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2017-12-08